- Canopy Growth has introduced its established Tweed brand to the German medical cannabis market, launching four new EU-cultivated strains through a partnership with Portuguese cultivator Gro-Vida. - The expansion includes high-THC genetics with sativa-dominant Jack Herer, indica-prominent Balanced Caramel and Wappa, and hybrid Gelato 33 strains, following December's Glitter Bomb launch with Cansativa. - This strategic move strengthens Canopy Growth's position in the German medical cannabis sector by ensuring consistent supply through EU-GMP facilities and partnerships with European cultivators.

Feb 27, 2025

返回机构列表

Canopy Growth Corporation

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（10）

A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality

CBD in Postmenopausal Women With Osteopenia

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants

Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity

Canadian Registry for the Use of Spectrum Therapeutics Cannabis Products in Subjects With Chronic Pain

The Effects of CBD Isolate on Menstrual-Related Symptoms

A Randomized Controlled Test of the Effects of CHI-554 on Fear.

CHI-907 CBD Extract and Experiences of Test Anxiety

药物批准

资讯

Canopy Growth Expands German Medical Cannabis Portfolio with Tweed Brand Launch